Diet and genetic risk for prostate cancer (Results from Carotene and Retinol Efficacy Trial = CARET)

PI:  Dr. Marian Neuhouser

This study investigated supplement use and prostate cancer risk in CARET.  After an average of 11 years of follow-up, 890 prostate cancer cases were reported.  We are examining variation in oxidative stress regulatory genes and serum based measures of antioxidants, such as tocopherols and carotenoids in relation to prostate cancer risk.